Patents by Inventor Laura Calabresi

Laura Calabresi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20240016824
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: July 21, 2023
    Publication date: January 18, 2024
    Applicant: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • CER-001 therapy for treating kidney disease
    Patent number: 11752163
    Abstract: Disclosed herein is the use of CER-001, a negatively charged lipoprotein complex which comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1?-rac-glycerol) (Dipalmitoylphosphatidyl-glycerol; DPPG) for treating kidney diseases, and methods for treating a subject having kidney diseases with CER-001. For example, the kidney disease can be associated with a lecithin cholesterol acyl transferase (LCAT) deficiency.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: September 12, 2023
    Assignee: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20210322448
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes